BRAF V600E mutation-positive metastatic melanoma

Zelboraf for metastatic melanoma approved by FDA

  Ordering Zelboraf   On Wednesday, August 17, the Food and Drug Administration approved Zelboraf, a drug for BRAF V600E…

13 years ago